Weighted Average Number of Shares Outstanding, Diluted of Yubo International Biotech Ltd from 2018 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Yubo International Biotech Ltd quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2018 to Q3 2025.
  • Yubo International Biotech Ltd Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 148M shares, a 23.4% increase year-over-year.
  • Yubo International Biotech Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 120M shares, a 900% increase from 2023.
  • Yubo International Biotech Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 12M shares.
  • Yubo International Biotech Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2019 was 1.18M shares, unchanged from 2018.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)

Yubo International Biotech Ltd Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 148M +28.1M +23.4% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 120M 0 0% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q1 2025 120M +108M +900% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 120M Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 120M 0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 120M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 12M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q3 2023 120M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q4 2020 89.7M +88.5M +7505% Sep 1, 2020 Nov 30, 2020 10-Q 2021-01-19
Q3 2020 1.18M 0 0% Jun 1, 2020 Aug 31, 2020 10-Q 2020-10-20
Q4 2019 1.18M Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-19
Q3 2019 1.18M Jun 1, 2019 Aug 31, 2019 10-Q 2020-10-20

Yubo International Biotech Ltd Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 120M +108M +900% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 12M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2019 1.18M 0 0% Mar 1, 2019 Feb 29, 2020 10-KT 2021-04-23
2018 1.18M Mar 1, 2018 Feb 28, 2019 10-KT 2021-04-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.